Review the updated evaluation framework for LUTS/BPH including new pre-procedural requirements

Summarize evidence for medical therapies — alpha blockers, 5-ARIs, PDE5 inhibitors, combination regimens

Understand how to select procedural therapy using the 2026 prostate size–based algorithm

Identify key changes from 2021: two new devices, updated retreatment data, no-stepwise-approach statement

Counsel patients on ejaculatory preservation trade-offs and retreatment risk